Arizona supplements seller sentenced, company ordered to forfeit $1.8 million and shut down
Federal authorities are intensifying enforcement against unapproved performance-enhancing substances sold into the U.S. market. In Arizona, Jeffrey McIndoo and his business SARMS Pharm are sentenced over the illicit sale and smuggling of selective androgen receptor modulators, or SARMs, which are not approved by the FDA.
Highlights
- McIndoo of Phoenix sentenced to four months in prison and fined $1,000 for introducing an unapproved drug into interstate commerce.
- JeffMac Investments LLC, operating as SARMS Pharm LLC, must forfeit $1.8 million and permanently cease operations after pleading guilty to smuggling SARMs from China.
- SARMS Pharm generated at least $3.5 million in gross profits from SARMs sales between 2017 and 2022, with the forfeiture covering part of the proceeds.
Sentencing and forfeiture order
As reported by U.S. Department of Justice, McIndoo, of Phoenix, receives a four-month prison sentence and a $1,000 fine after admitting to introducing an unapproved drug into interstate commerce.JeffMac Investments LLC, doing business as SARMS Pharm LLC, pleaded guilty to conspiracy to smuggle SARMs from China into the United States. Judge Sharad H. Desai of the District of Arizona also orders the company to cease operations and forfeit $1.8 million in proceeds tied to the unlawful conduct.
SARMs mimic the effects of anabolic steroids when ingested and are not approved by the U.S. Food & Drug Administration. The Justice Department says the substances were sold despite federal safeguards intended to protect public health.
Business proceeds and enforcement impact
Court details cited by the department show SARMS Pharm earns at least $3.5 million in gross profits from SARMs sales between 2017 and 2022. The $1.8 million forfeiture covers part of the proceeds retained by the company as part of its plea agreement.Assistant Attorney General Brett A. Shumate says the defendants bypassed key public health protections by smuggling and selling unapproved SARMs. The case is investigated by the FDA's Office of Criminal Investigations, while Managing Attorney David Sullivan and Assistant Director Patrick Runkle of the Civil Division's Enforcement & Affirmative Litigation Branch prosecute it.
Our earlier coverage of Nigeria’s NAFDAC crackdown on unsafe and falsified regulated products highlighted how the regulator destroyed goods worth N22.73 billion within eight months as part of tighter oversight of the food and drug supply chain. We noted that the intensified enforcement increased compliance pressure on importers, distributors, and retailers while aiming to reduce consumer exposure to harmful products.